Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva
-
Mendus to participate in several investor and industry conferences in January
-
PR : Iktos and Nerviano Medical Sciences S.r.l Announce Collaboration in Artificial Intelligence for New Drug Discovery
-
Riber: Order for MBE production machine and services in Europe
-
Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold
-
Orion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCs
-
Boussard & Gavaudan Holding Ltd (GBP): Application for listing of Euro Shares following Share Conversion
-
Boussard & Gavaudan Holding Ltd (EUR): Application for listing of Euro Shares following Share Conversion
-
MICROVAST HOLDINGS, INC. (NASDAQ: MVST) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Microvast
-
DRIVEN BRANDS HOLDINGS INC. (NASDAQ: DRVN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Driven
-
ON SEMICONDUCTOR CORPORATION (NASDAQ: ON) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ON Semic
-
THE ESTÉE LAUDER COMPANIES INC. (NYSE: EL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against The
-
INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire
-
MERCURY SYSTEMS, INC. (NASDAQ: MRCY) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Mercury Syste
-
NATIONAL INSTRUMENTS CORPORATION DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against National Instrume
-
EHANG HOLDINGS LIMITED (NASDAQ: EH) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against EHang Holdings
-
DOLLAR GENERAL CORPORATION (NYSE: DG) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Dollar Gener
-
EXPENSIFY, INC. (NASDAQ: EXFY) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Expensify, Inc.
-
CHARGEPOINT HOLDINGS, INC. (NYSE: CHPT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ChargePoin
-
FISKER INC. (NYSE: FSR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fisker Inc.
-
ROBLOX CORPORATION (NYSE: RBLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Roblox Corporation
-
Groupe Casino: Update on financial restructuring conditions precedent; European Commission merger control clearance
-
BW Offshore: BW Catcher FPSO contract extended beyond fixed term
-
Transaction in Own Shares
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Nicox : Half-year liquidity contract statement with Kepler Cheuvreux as of December 31, 2023
-
TomTom and Mitsubishi Electric collaborate to advance Automated Driving
-
Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard‐of‐care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia
-
Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard‐of‐care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia
-
Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard‐of‐care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia
-
argenx Highlights 2024 Strategic Priorities
-
Start of Day Message
-
TGS Announces Prefunding on 2D Multi-Client Seismic Project Offshore Sabah, Malaysia
-
argenx Highlights 2024 Strategic Priorities
-
Flex LNG - Redelivery of Flex Constellation in 2024
-
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
-
Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024
-
PGS Announces Pre-funded 2D MultiClient Project Offshore Sabah, Malaysia
-
Flash News: OKX DEX API Integrated by XY Finance, a Cross-Chain Interoperability Protocol
-
Flash News: OKX to List Solana-Based Jito (JTO) and Bonk (BONK) Tokens on its Spot Market
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Driven, and Maison Solutions and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm
-
Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases
-
Ascendis Pharma Introduces Vision 2030
-
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
-
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
-
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
-
Erika Skaar Appointed as MRI Clinical Sales Specialist
